MedKoo Cat#: 592225 | Name: Mitopodozide

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Mitopodozide is an ethylhydrazide derivative of podophyllic acid. It acts as a mitotic poison in carcinomas of the ovary.

Chemical Structure

 Mitopodozide
Mitopodozide
CAS#1508-45-8

Theoretical Analysis

MedKoo Cat#: 592225

Name: Mitopodozide

CAS#: 1508-45-8

Chemical Formula: C24H30N2O8

Exact Mass: 474.2002

Molecular Weight: 474.51

Elemental Analysis: C, 60.75; H, 6.37; N, 5.90; O, 26.97

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Mitopodozide; SP-I 77; SPI 77; SPI-77
IUPAC/Chemical Name
Naphtho(2,3-d)-1,3-dioxole-6-carboxylic acid, 5,6,7,8-tetrahydro-8-hydroxy-7-(hydroxymethyl)-5-(3,4,5-trimethoxyphenyl)-, 2-ethylhydrazide, (5R-(5alpha,6alpha,7beta,8alpha))- (9CI)
InChi Key
CPTIBDHUFVHUJK-NZYDNVMFSA-N
InChi Code
InChI=1S/C24H30N2O8/c1-5-25-26-24(29)21-15(10-27)22(28)14-9-17-16(33-11-34-17)8-13(14)20(21)12-6-18(30-2)23(32-4)19(7-12)31-3/h6-9,15,20-22,25,27-28H,5,10-11H2,1-4H3,(H,26,29)/t15-,20+,21-,22-/m0/s1
SMILES Code
O=C([C@H]1[C@H](CO)[C@@H](O)C2=C(C=C3OCOC3=C2)[C@H]1C4=CC(OC)=C(OC)C(OC)=C4)NNCC
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 474.51 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Shi J, Wang X, Qiu J, Si Q, Sun R, Guo H, Wu Q. Roles of NF-kappaB and SP-1 in oxidative stress-mediated induction of platelet-derived growth factor-B by TNFalpha in human endothelial cells. J Cardiovasc Pharmacol. 2004 Jul;44(1):26-34. PubMed PMID: 15175554. 2: Ma Z, Shah RC, Chang MJ, Benveniste EN. Coordination of cell signaling, chromatin remodeling, histone modifications, and regulator recruitment in human matrix metalloproteinase 9 gene transcription. Mol Cell Biol. 2004 Jun;24(12):5496-509. PubMed PMID: 15169910; PubMed Central PMCID: PMC419859. 3: Kuwahara J, Watanabe Y, Kayasuga T, Itoh K. Zn finger and nuclear localization of transcription factor Sp1. Nucleic Acids Symp Ser. 2000;(44):265-6. PubMed PMID: 12903370. 4: Xie RL, Gupta S, Miele A, Shiffman D, Stein JL, Stein GS, van Wijnen AJ. The tumor suppressor interferon regulatory factor 1 interferes with SP1 activation to repress the human CDK2 promoter. J Biol Chem. 2003 Jul 18;278(29):26589-96. Epub 2003 May 5. PubMed PMID: 12732645. 5: Ohkawara S, Yokoyama C, Shimonishi M, Tanabe T. Analysis of the transcriptional regulation of mouse prostacyclin synthase gene. Adv Exp Med Biol. 2002;507:281-6. PubMed PMID: 12664598. 6: Hilton TL, Wang EH. Transcription factor IID recruitment and Sp1 activation. Dual function of TAF1 in cyclin D1 transcription. J Biol Chem. 2003 Apr 11;278(15):12992-3002. Epub 2003 Feb 4. PubMed PMID: 12569092. 7: Miyatake R, Furukawa A, Suwaki H. Identification of a novel variant of the human NR2B gene promoter region and its possible association with schizophrenia. Mol Psychiatry. 2002;7(10):1101-6. PubMed PMID: 12476325. 8: Prasad AS, Bao B, Beck FW, Sarkar FH. Zinc enhances the expression of interleukin-2 and interleukin-2 receptors in HUT-78 cells by way of NF-kappaB activation. J Lab Clin Med. 2002 Oct;140(4):272-89. PubMed PMID: 12389026. 9: Lee YW, Son KW, Flora G, Hennig B, Nath A, Toborek M. Methamphetamine activates DNA binding of specific redox-responsive transcription factors in mouse brain. J Neurosci Res. 2002 Oct 1;70(1):82-9. PubMed PMID: 12237866. 10: Zampieri L, Bianchi P, Ruff P, Arbuthnot P. Differential modulation by estradiol of P-glycoprotein drug resistance protein expression in cultured MCF7 and T47D breast cancer cells. Anticancer Res. 2002 Jul-Aug;22(4):2253-9. PubMed PMID: 12174911. 11: Li WG, Zhang XY, Wu YJ, Tian X. Antioxidative activity of spin labeled derivatives of podophyllic acid hydrazide. Acta Pharmacol Sin. 2002 Aug;23(8):727-32. PubMed PMID: 12147195. 12: Singh J, Murata K, Itahana Y, Desprez PY. Constitutive expression of the Id-1 promoter in human metastatic breast cancer cells is linked with the loss of NF-1/Rb/HDAC-1 transcription repressor complex. Oncogene. 2002 Mar 14;21(12):1812-22. PubMed PMID: 11896613. 13: Mori N, Sato H, Hayashibara T, Senba M, Hayashi T, Yamada Y, Kamihira S, Ikeda S, Yamasaki Y, Morikawa S, Tomonaga M, Geleziunas R, Yamamoto N. Human T-cell leukemia virus type I Tax transactivates the matrix metalloproteinase-9 gene: potential role in mediating adult T-cell leukemia invasiveness. Blood. 2002 Feb 15;99(4):1341-9. PubMed PMID: 11830485. 14: Fialová L, Matous-Malbohan I, Mikulíková L, Benesová O, Krofta L, Zwinger A. [PAPP-A in the first trimester of pregnancy]. Ceska Gynekol. 2001 Jul;66(4):280-5. Czech. PubMed PMID: 11569426. 15: van Rietschoten JG, Smits HH, van de Wetering D, Westland R, Verweij CL, den Hartog MT, Wierenga EA. Silencer activity of NFATc2 in the interleukin-12 receptor beta 2 proximal promoter in human T helper cells. J Biol Chem. 2001 Sep 14;276(37):34509-16. Epub 2001 Jul 3. PubMed PMID: 11438525. 16: Denson LA, Menon RK, Shaufl A, Bajwa HS, Williams CR, Karpen SJ. TNF-alpha downregulates murine hepatic growth hormone receptor expression by inhibiting Sp1 and Sp3 binding. J Clin Invest. 2001 Jun;107(11):1451-8. PubMed PMID: 11390427; PubMed Central PMCID: PMC209317. 17: Veal GJ, Griffin MJ, Price E, Parry A, Dick GS, Little MA, Yule SM, Morland B, Estlin EJ, Hale JP, Pearson AD, Welbank H, Boddy AV. A phase I study in paediatric patients to evaluate the safety and pharmacokinetics of SPI-77, a liposome encapsulated formulation of cisplatin. Br J Cancer. 2001 Apr 20;84(8):1029-35. PubMed PMID: 11308249; PubMed Central PMCID: PMC2363870. 18: Ben-Shushan E, Marshak S, Shoshkes M, Cerasi E, Melloul D. A pancreatic beta -cell-specific enhancer in the human PDX-1 gene is regulated by hepatocyte nuclear factor 3beta (HNF-3beta ), HNF-1alpha, and SPs transcription factors. J Biol Chem. 2001 May 18;276(20):17533-40. Epub 2001 Feb 5. PubMed PMID: 11278466. 19: Weigert C, Sauer U, Brodbeck K, Pfeiffer A, Häring HU, Schleicher ED. AP-1 proteins mediate hyperglycemia-induced activation of the human TGF-beta1 promoter in mesangial cells. J Am Soc Nephrol. 2000 Nov;11(11):2007-16. PubMed PMID: 11053476. 20: Berhane K, Margana RK, Boggaram V. Characterization of rabbit SP-B promoter region responsive to downregulation by tumor necrosis factor-alpha. Am J Physiol Lung Cell Mol Physiol. 2000 Nov;279(5):L806-14. PubMed PMID: 11053014.